117 related articles for article (PubMed ID: 14561264)
1. False-positive result and reattendance in the Ontario Breast Screening Program.
Chiarelli AM; Moravan V; Halapy E; Majpruz V; Mai V; Tatla RK
J Med Screen; 2003; 10(3):129-33. PubMed ID: 14561264
[TBL] [Abstract][Full Text] [Related]
2. Organized breast screening improves reattendance compared to physician referral: a case control study.
Makedonov I; Gu S; Paszat LF;
BMC Cancer; 2015 Apr; 15():315. PubMed ID: 25928416
[TBL] [Abstract][Full Text] [Related]
3. The effect of false positive breast screening examinations on subsequent attendance: retrospective cohort study.
Maxwell AJ; Beattie C; Lavelle J; Lyburn I; Sinnatamby R; Garnett S; Herbert A
J Med Screen; 2013 Jun; 20(2):91-8. PubMed ID: 24009091
[TBL] [Abstract][Full Text] [Related]
4. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic status & returning for a second screen in the Ontario breast screening program.
Tatla RK; Paszat LF; Bondy SJ; Chen Z; Chiarelli AM; Mai V
Breast; 2003 Aug; 12(4):237-46. PubMed ID: 14659307
[TBL] [Abstract][Full Text] [Related]
6. The contribution of clinical breast examination to the accuracy of breast screening.
Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
[TBL] [Abstract][Full Text] [Related]
7. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
8. False positive results do not have a negative effect on reattendance for subsequent breast screening.
O'Sullivan I; Sutton S; Dixon S; Perry N
J Med Screen; 2001; 8(3):145-8. PubMed ID: 11678554
[TBL] [Abstract][Full Text] [Related]
9. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
[TBL] [Abstract][Full Text] [Related]
10. Breast screening outcomes in women with and without a family history of breast and/or ovarian cancer.
Halapy EE; Chiarelli AM; Klar N; Knight J
J Med Screen; 2004; 11(1):32-8. PubMed ID: 15006112
[TBL] [Abstract][Full Text] [Related]
11. Impact of false-positive mammography on subsequent screening attendance and risk of cancer.
McCann J; Stockton D; Godward S
Breast Cancer Res; 2002; 4(5):R11. PubMed ID: 12223128
[TBL] [Abstract][Full Text] [Related]
12. Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000.
Chiarelli AM; Halapy E; Nadalin V; Shumak R; O'Malley F; Mai V
Eur J Cancer Prev; 2006 Feb; 15(1):34-42. PubMed ID: 16374227
[TBL] [Abstract][Full Text] [Related]
13. Results from the Ontario breast screening program, 1990-1995.
Libstug AR; Moravan V; Aitken SE
J Med Screen; 1998; 5(2):73-80. PubMed ID: 9718525
[TBL] [Abstract][Full Text] [Related]
14. Satisfaction with initial screen and compliance with biennial breast screening at centers with and without nurses.
Edwards SA; Chiarelli AM; Ritvo P; Stewart L; Majpruz V; Mai V
Cancer Nurs; 2011; 34(4):293-301. PubMed ID: 21681146
[TBL] [Abstract][Full Text] [Related]
15. Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening Program.
Chiarelli AM; Mai V; Halapy EE; Shumak RS; O'Malley FP; Klar NS
Can J Public Health; 2005; 96(4):259-63. PubMed ID: 16625791
[TBL] [Abstract][Full Text] [Related]
16. Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.
Eisen A; Blackmore KM; Meschino WS; Muradali D; Carroll JC; Majpruz V; Warner E; Rabeneck L; Chiarelli AM
Mol Genet Genomic Med; 2018 Mar; 6(2):213-223. PubMed ID: 29368425
[TBL] [Abstract][Full Text] [Related]
17. The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer.
Smith CR; Chiarelli AM; Holloway CM; Mirea L; O'Malley FP; Blackmore KM; Pandya A; Majpruz V; Harris CP; Hendry A; Hey A; Kornecki A; Lougheed G; Maier BA; Marchand P; McCready D; Rand C; Raphael S; Segal-Nadler R; Sehgal N; Muradali D
Breast; 2018 Oct; 41():25-33. PubMed ID: 29957557
[TBL] [Abstract][Full Text] [Related]
18. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
Castells X; Molins E; Macià F
J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348
[TBL] [Abstract][Full Text] [Related]
19. Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer.
Mittmann N; Seung SJ; Diong C; Gatley JM; Wolfson M; Guertin MH; Pashayan N; Simard J; Chiarelli AM
Curr Oncol; 2022 Oct; 29(11):8330-8339. PubMed ID: 36354717
[TBL] [Abstract][Full Text] [Related]
20. Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study.
Habbous S; Homenauth E; Barisic A; Kandasamy S; Majpruz V; Forster K; Yurcan M; Chiarelli AM; Groome P; Holloway CMB; Eisen A
CMAJ Open; 2022; 10(2):E313-E330. PubMed ID: 35383035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
